What is the primary objective of GMP?

The primary objective of GMP is to ensure products are consistently produced and controlled to meet predefined quality standards, preventing contamination, mix-ups, mislabeling, and variability through preventive controls rather than end-product testing alone. This encompasses the "5 Ps"—People, Products, Procedures, Processes, and Premises—as defined in FDA 21 CFR Parts 210/211, EU EudraLex Volume 4, and WHO GMP, assuring identity, strength, quality, and purity via validated processes, independent quality oversight, and traceability.

Who is legally or professionally required to comply with GMP?

GMP compliance is legally required for manufacturers of pharmaceuticals, biologics, APIs, and related products under FDA 21 CFR Parts 210/211 in the U.S., EU GMP in EudraLex Volume 4, and WHO GMP globally. This includes contract manufacturers (CMOs), API producers per ICH Q7, and organizations with a Quality Control Unit or Qualified Person (QP) responsible for batch release, spanning raw material receipt to distribution to protect public health.

Does GMP require an external audit or third-party certification?

GMP does not universally mandate third-party certification but requires internal audits, self-inspections, and is enforced through mandatory regulatory inspections by authorities like FDA or EMA. Organizations must maintain independent quality units for oversight, with PIC/S and MRAs enabling mutual recognition, but compliance is verified via unannounced inspections rather than optional ISO-style certification.

How often should an assessment for GMP be performed?

GMP assessments, including internal audits and self-inspections, must be conducted at planned risk-based intervals, typically annually, with ad-hoc reviews triggered by changes, deviations, or CAPA outcomes. FDA and EU GMP require ongoing monitoring via Product Quality Reviews (PQR) (annual per 21 CFR §211.180(e)) and management reviews (ICH Q10), ensuring continual improvement and state of control.

What are the consequences of non-compliance with GMP?

Non-compliance with GMP results in regulatory actions including Form 483 observations, Warning Letters, import alerts, product seizures, recalls, fines up to $50k per day (FDA), manufacturing halts, and potential criminal liability. Historical cases like Elixir Sulfanilamide underscore risks of patient harm, market exclusion, and multimillion-dollar remediation costs.

Can GMP be mapped to other international frameworks?

GMP aligns closely with ICH guidelines like Q7 (API GMP), Q9 (QRM), and Q10 (PQS), plus PIC/S for inspection harmonization, enabling mapping across FDA, EU, and WHO regimes. Core elements—quality systems, validation, documentation—converge, though EU Annexes (e.g., Annex 1 sterile products since 25 Aug 2024) add specificity.

What is the first step to begin implementing GMP?

The first step to implement GMP is conducting a comprehensive gap analysis against applicable regulations (e.g., 21 CFR Part 211, EU GMP) to develop a Validation Master Plan (VMP) and remediation roadmap. This identifies risks, prioritizes controls, and secures executive sponsorship for PQS, training, and validation.

What is the primary objective of ISO 22301?

ISO 22301 specifies requirements for establishing, implementing, maintaining, and continually improving a Business Continuity Management System (BCMS). It enables organizations to protect against, reduce the likelihood of, and recover from disruptive incidents while ensuring continuity of critical products and services, structured around a PDCA (Plan-Do-Check-Act) cycle across 10 clauses.

Who is legally or professionally required to comply with ISO 22301?

ISO 22301 applies to organizations of all sizes and sectors seeking resilience, with heightened professional relevance in critical sectors like utilities, transport, health, finance, and IT services. It is not universally legally mandated but supports regulatory compliance such as the EU's NIS Directive for essential services providers, where BCM is required to mitigate risks like cyberattacks and supply chain failures.

Does ISO 22301 require an external audit or third-party certification?

ISO 22301 certification requires a two-stage external audit by an accredited body: Stage 1 (readiness review) and Stage 2 (effectiveness audit), typically taking 6-8 weeks. Certification is valid for 3 years, with mandatory annual surveillance audits and internal audits to verify BCMS performance per Clause 9.

How often should an assessment for ISO 22301 be performed?

Internal audits and management reviews for ISO 22301 must be conducted at planned intervals, typically annually, with continual monitoring per Clause 9. The full standard undergoes systematic review every 5 years, as seen with the 2019 edition's review and the 2024 Amendment 1 on climate action.

What are the consequences of non-compliance with ISO 22301?

Non-compliance with ISO 22301 exposes organizations to unmitigated disruptions, financial losses, reputational damage, and regulatory penalties in mandated sectors. Certified organizations avoid these via tested BCMS, but lapses in BIA, testing, or audits can lead to certification revocation after 3 years without surveillance adherence.

Can ISO 22301 be mapped to other international frameworks?

Yes, ISO 22301 seamlessly maps to frameworks sharing Annex SL high-level structure, such as ISO 27001 for integrated BCMS and information security management. Its PDCA model aligns with ISO 31000 risk guidelines and ISO 22313 BCMS guidance, enabling bundled implementations for holistic resilience.

What is the first step to begin implementing ISO 22301?

The first step for ISO 22301 implementation is conducting a gap analysis against Clauses 4-10, starting with Clause 4's understanding of organizational context, internal/external issues, and interested parties. This informs BIA, secures leadership commitment (Clause 5), and defines BCMS scope.

Standards Comparison

GMP vs ISO 22301

GMP

Mandatory

1963

Regulatory framework ensuring consistent pharmaceutical manufacturing quality

ISO 22301

Voluntary

2019

International standard for business continuity management systems.

Quick Verdict

GMP ensures manufacturing quality and safety in pharma via preventive controls and inspections, while ISO 22301 builds business continuity resilience across sectors through BIA and testing. Companies adopt GMP for regulatory compliance and patient protection; ISO 22301 for disruption recovery and stakeholder trust.

Manufacturing Quality

GMP

Good Manufacturing Practice (GMP)

Cost

€€€€

Complexity

Medium

Implementation Time

18-24 months

Key Features

Mandates preventive controls beyond final product testing
Requires independent quality unit for batch approval
Integrates risk-based Quality Risk Management principles
Enforces process validation and equipment qualification
Demands rigorous documentation and data integrity

Business Continuity

ISO 22301

ISO 22301:2019 Business continuity management systems

Cost

€€€

Complexity

High

Implementation Time

0-6 months

Key Features

PDCA cycle for continual BCMS improvement
Business Impact Analysis (BIA) and risk assessment
Leadership commitment with policy and roles
Operational testing of recovery strategies
Annex SL integration with ISO 27001

Detailed Analysis

A comprehensive look at the specific requirements, scope, and impact of each standard.

GMP Details

What It Is

Good Manufacturing Practice (GMP) is a regulatory framework of minimum enforceable standards for manufacturing pharmaceuticals, biologics, and related products. It ensures products are consistently produced to meet quality, safety, and purity criteria through preventive controls spanning facilities, equipment, processes, personnel, and records. Key approach is risk-based via Quality Risk Management (QRM), emphasizing design-in quality over end-testing.

Key Components

Core pillars: 5 Ps (People, Premises, Processes, Procedures, Products)
Elements include quality systems (PQS per ICH Q10), validation, documentation (ALCOA++), CAPA, supplier controls, and audits
Built on ICH Q9/Q10, FDA 21 CFR 210/211, EU EudraLex Vol. 4, WHO GMP
Compliance via inspections, no central certification but enforceable regionally

Why Organizations Use It

Mandated for market access; prevents recalls, contamination, liability. Drives efficiency, supply reliability, patient protection. Builds regulator trust, reduces remediation costs, enables global trade via harmonization (PIC/S, MRAs).

Implementation Overview

Phased: gap analysis, VMP, validation (DQ/IQ/OQ/PQ), training, audits. Applies to pharma/biologics manufacturers globally; scales by size/risk. Ongoing via internal audits, management review.

ISO 22301 Details

What It Is

ISO 22301:2019 is the international certification standard for Business Continuity Management Systems (BCMS). It establishes requirements to plan, implement, monitor, and improve resilience against disruptions like cyberattacks, pandemics, and natural disasters using a PDCA (Plan-Do-Check-Act) cycle and risk-based approach.

Key Components

10 clauses (4-10 core): context, leadership, planning (BIA, risk assessment), support, operations (recovery strategies, testing), evaluation (audits, reviews), improvement.
No prescriptive controls; flexible, tailored to organization.
Built on Annex SL for integration with ISO 27001, 31000.
3-year certification with annual surveillance audits.

Why Organizations Use It

Mitigates downtime, financial losses; enhances recovery (e.g., RTOs).
Meets regulations (NIS, NIST); builds stakeholder trust, reputation.
Provides competitive edges, lower insurance, procurement advantages.
Fosters proactive resilience culture amid rising global risks.

Implementation Overview

Phased: gap analysis, BIA, documentation, training, testing, audits.
60 days to 6 months typical; suits all sizes/sectors.
Two-stage certification (readiness, effectiveness); tools accelerate.

Key Differences

Aspect	GMP	ISO 22301
Scope	Manufacturing controls for product quality/safety	Business continuity management system resilience
Industry	Pharma, biologics, food, cosmetics globally	All sectors worldwide, any organization size
Nature	Enforceable regulations with inspections	Voluntary certification standard
Testing	Process/equipment validation, audits	BIA, exercises, internal/external audits
Penalties	Warning letters, recalls, fines	Loss of certification, no legal penalties

Scope

GMP

Manufacturing controls for product quality/safety

ISO 22301

Business continuity management system resilience

Industry

GMP

Pharma, biologics, food, cosmetics globally

ISO 22301

All sectors worldwide, any organization size

Nature

GMP

Enforceable regulations with inspections

ISO 22301

Voluntary certification standard

Testing

GMP

Process/equipment validation, audits

ISO 22301

BIA, exercises, internal/external audits

Penalties

GMP

Warning letters, recalls, fines

ISO 22301

Loss of certification, no legal penalties

Frequently Asked Questions

Common questions about GMP and ISO 22301

GMP FAQ

ISO 22301 FAQ

You Might also be Interested in These Articles...

SOC 2 for Fintech Startups: First 5 Steps to Compliance with Confidentiality Criterion Infographic

First 5 steps to SOC 2 compliance with Confidentiality for fintech SaaS. Infographic maps controls to risks like encryption & TPRM. Integrates GLBA/PCI DSS over

CIS Controls v8.1, Operationalized: Top 10 Reasons Compliance Monitoring Software Accelerates Real-World Implementation

Operationalize CIS Controls v8.1 with compliance monitoring software. Turn checklists into dashboards, tickets, and audit-proof workflows. Top 10 reasons it acc

From Reactive Gatekeeper to Proactive Strategist: How Compliance Software Reshapes the Compliance Professional's Day

Discover how compliance software automates monitoring, delivers real-time insights, and transforms compliance pros from reactive gatekeepers to proactive strate

Run Maturity Assessments with GRADUM

Transform your compliance journey with our AI-powered assessment platform

Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

100+ Standards & Regulations

AI-Powered Insights

Collaborative Assessments

Actionable Recommendations

Explore More Comparisons

See how GMP and ISO 22301 compare against other standards

Other GMP Comparisons

Other ISO 22301 Comparisons

Quick Verdict

What It Is

Key Components

Core pillars: 5 Ps (People, Premises, Processes, Procedures, Products)

Elements include quality systems (PQS per ICH Q10), validation, documentation (ALCOA++), CAPA, supplier controls, and audits

Built on ICH Q9/Q10, FDA 21 CFR 210/211, EU EudraLex Vol. 4, WHO GMP

Compliance via inspections, no central certification but enforceable regionally

What It Is

Key Components

10 clauses (4-10 core): context, leadership, planning (BIA, risk assessment), support, operations (recovery strategies, testing), evaluation (audits, reviews), improvement.

No prescriptive controls; flexible, tailored to organization.

Built on Annex SL for integration with ISO 27001, 31000.

3-year certification with annual surveillance audits.

Aspect

GMP

ISO 22301

Scope

Manufacturing controls for product quality/safety

Business continuity management system resilience

Industry

Pharma, biologics, food, cosmetics globally

All sectors worldwide, any organization size

Nature

Enforceable regulations with inspections

Voluntary certification standard

Testing

Process/equipment validation, audits

BIA, exercises, internal/external audits

Penalties

Warning letters, recalls, fines

Loss of certification, no legal penalties